GoodRx Holdings, Inc. (GDRX) Misses Q4 EPS by 1c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Raymond James Reiterates Strong Buy Rating on GoodRx Holdings Inc. (GDRX)
February 27, 2025 4:05 PM ESTRaymond James analyst Aaron Kessler reiterated a Strong Buy rating and $9.00 price target on GoodRx Holdings Inc. (NASDAQ: GDRX).
The analyst comments "All in all, it was a solid quarter, and we expect a more stable cadence of expectations/earnings... More
GoodRx Holdings Inc. (GDRX) PT Raised to $6.75 at Citi
February 27, 2025 3:15 PM ESTCiti analyst Daniel Grosslight raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $6.75 (from $6.25) while maintaining a Buy rating.
The analyst comments "After a couple quarters of excess volatility, GDRXs 4Q results should be a bit of a reprieve for... More
